Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
Infrastructure of Support
Cure, Deerfield’s Innovation Campus Deerfield Discovery & Development External Operations Genscience | Human Genetic Foresight
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Investment
Portfolio Oversight Healthcare Services Medical Technologies Therapeutics Business Development Public Structured Finance Trading
Deerfield Discovery & Development (3DC)
Deerfield Institute
Data Analytics and Development Information Research
Internal Operations
Administration Building Operations Finance Human Resources Legal and Compliance Information Technology
External Operations
Partnership & Communications
Featured
Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry Deerfield Management Launches Joint Venture with Horizon Blue Cross Blue Shield of New Jersey Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
News by Type
Press Release Insights
News by Industry
Therapeutics Healthcare Services Medical Technologies Cross-industry
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Foundation Partners by Focus
Children's Health Diversity Initiatives Maternal Health View All
Founded Diversity Programs
Break into the Boardroom Fellowships Science to the Street (formerly Women in Science)
---
Cure Campus

Cure is a 12-story innovation campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure
Explore the healthcare ecosystem

Omnigen

Status of Investment|Current
Industry|Healthcare Services and IT

Initial Transaction Details

Amount | Undisclosed
Transaction Date | June 2021
Purpose of Financing|Special Situations
Stage of Company|Early Stage
Structure of Financing|Debt and Equity

Omnigen Biodata (Omnigen) is a biotechnology company based in Cambridge, UK.

Omnigen is building a global research community through its Discover Me research platform, integrating health and genetic data on hundreds of thousands of people. This will help individuals understand their health and care better, and inform their own health decisions. The research platform will also enable discovery science and precision medicine clinical trials.

Website